BioPharma

PolyNovo (ASX:PNV) has announced that the first patient has been enrolled in its trial evaluating the clinical safety and efficacy of its NovoSorb SynPath for the treatment of chronic diabetic foot ulcers.

Therapeutic antibody development company Patrys (ASX:PAB) has announced new pre-clinical data for its lead asset, PAT-DX1, from a study conducted by Professor Terrence Johns of the Telethon Kids Cancer Centre.

Health minister Mark Butler has announced that the federal government has scrapped the "wasteful and ineffective" COVIDSafe app.

Leading private health insurance intermediary iSelect will be acquired by Innovation Holdings Australia under a deal that values the company at $72 million.

A new report commissioned by Medibank has found that a short stay in hospital program, accompanied by at home care, could reduce the burden on the health system.

The industry has already engaged political stakeholders on the impact of the new PBS pricing framework but it is likely to get more intense in October and November with major decisions and four critical sitting weeks of the parliament.

A group of UK researchers, leading biopharmaceutical companies and industry groups have called on the country's National Health Service to take a dramatic step forward by introducing genetic profiling of every patient's cancer following diagnosis and during treatment.

Starpharma has announced a new research agreement under which it will design and synthesise a number of DEP dendrimer conjugates and provide them to MSD.

BIO president and CEO Dr Michelle McMurry-Heath said the only certain outcome from the change will be "fewer cures for patients."

The hearing's presiding officer challenged the line of questioning, saying an outcome that 'disadvantages' the Commonwealth is not relevant to the hearing or Freedom of Information laws.

The industry is significantly focused on the implications of next April's 'catch-up' statutory price reductions but it might need to take a wider view of what are much broader and fundamental changes to the policy infrastructure of the PBS that will have an enduring impact.

The Victorian government has provided $5.4 million to a collaboration involving researchers from Monash University and the University of Melbourne to establish the state's mRNA Innovation Hub.